Literature DB >> 10624541

Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism.

T A Kimbrell1, J T Little, R T Dunn, M A Frye, B D Greenberg, E M Wassermann, J D Repella, A L Danielson, M W Willis, B E Benson, A M Speer, E Osuch, M S George, R M Post.   

Abstract

BACKGROUND: Recent studies suggest that both high frequency (10-20 Hz) and low frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) have an antidepressant effect in some individuals. Electrophysiologic data indicate that high frequency rTMS enhances neuronal firing efficacy and that low frequency rTMS has the opposite effect.
METHODS: We investigated the antidepressant effects of 10 daily left prefrontal 1 Hz versus 20 Hz rTMS with the hypothesis that within a given subject, antidepressant response would differ by frequency and vary as a function of baseline cerebral glucose metabolism. After baseline PET scans utilizing [18F]-Fluorodeoxyglucose, thirteen subjects participated in a randomized crossover trial of 2 weeks of 20 Hz paired with 2 weeks 1 Hz or placebo rTMS.
RESULTS: We found a negative correlation between degree of antidepressant response after 1 Hz compared to 20 Hz rTMS (r = -0.797, p < .004). Additionally, better response to 20 Hz was associated with the degree of baseline hypometabolism, whereas response to 1 Hz rTMS tended to be associated with baseline hypermetabolism.
CONCLUSIONS: These preliminary results suggest that antidepressant response to rTMS might vary as a function of stimulation frequency and may depend on pretreatment cerebral metabolism. Further studies combining rTMS and functional neuroimaging are needed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624541     DOI: 10.1016/s0006-3223(99)00195-x

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  57 in total

Review 1.  Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.

Authors:  Fumiko Maeda; Alvaro Pascual-Leone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-26       Impact factor: 4.530

2.  rTMS stimulation on left DLPFC increases the correct recognition of memories for emotional target and distractor words.

Authors:  Michela Balconi; Chiara Ferrari
Journal:  Cogn Affect Behav Neurosci       Date:  2012-09       Impact factor: 3.282

3.  Clinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression.

Authors:  Alexander McGirr; Sneha Karmani; Rashmi Arsappa; Marcelo T Berlim; Jagadisha Thirthalli; Kesavan Muralidharan; Lakshmi N Yatham
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

4.  Variable changes in PET activity before and after rTMS treatment for tinnitus.

Authors:  Mark Mennemeier; Kenneth C Chelette; Shawn Allen; Twyla B Bartel; William Triggs; Timothy Kimbrell; Joseph Crew; Tiffany Munn; Ginger J Brown; John Dornhoffer
Journal:  Laryngoscope       Date:  2011-02-01       Impact factor: 3.325

5.  Interregional cerebral metabolic associativity during a continuous performance task (Part I): healthy adults.

Authors:  Mark W Willis; Brenda E Benson; Terence A Ketter; Tim A Kimbrell; Mark S George; Andrew M Speer; Peter Herscovitch; Robert M Post
Journal:  Psychiatry Res       Date:  2008-09-17       Impact factor: 3.222

6.  Repetitive TMS combined with exposure therapy for PTSD: a preliminary study.

Authors:  Elizabeth A Osuch; Brenda E Benson; David A Luckenbaugh; Marilla Geraci; Robert M Post; Una McCann
Journal:  J Anxiety Disord       Date:  2008-03-28

7.  The functional neuroanatomy of geriatric depression.

Authors:  Gwenn S Smith; Elisse Kramer; Yilong Ma; Peter Kingsley; Vijay Dhawan; Thomas Chaly; David Eidelberg
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

8.  Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Authors:  Matthew S Milak; Ramin V Parsey; Leilani Lee; Maria A Oquendo; Doreen M Olvet; Francoise Eipper; Kevin Malone; J John Mann
Journal:  Psychiatry Res       Date:  2009-05-14       Impact factor: 3.222

Review 9.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

Review 10.  Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review.

Authors:  Pablo Andrade; Lieke H M Noblesse; Yasin Temel; Linda Ackermans; Lee W Lim; Harry W M Steinbusch; Veerle Visser-Vandewalle
Journal:  Acta Neurochir (Wien)       Date:  2010-01-26       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.